UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 331

Sortiert nach

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial

Annals of oncology, 2020-10, Vol.31 (10), p.1350-1358

2020

Volltextzugriff (PDF)

Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

British journal of surgery, 2021-05, Vol.108 (5), p.583-589

2021

Volltextzugriff (PDF)

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

Annals of oncology, 2015-01, Vol.26 (1), p.81-88

2015

Volltextzugriff (PDF)

When to order a biopsy to characterise a metastatic relapse in breast cancer

Annals of oncology, 2012-09, Vol.23 Suppl 10, p.x349-x353

2012

Volltextzugriff (PDF)

Quantitation of cell loss in breast cancer during neoadjuvant treatment (NACT) assessed by serum thymidine kinase protein concentration (sTK1)

ANNALS OF ONCOLOGY, 2017-11, Vol.28, p.x22-x22

2017

Volltextzugriff (PDF)

PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels

ANNALS OF ONCOLOGY, 2020, Vol.31 (Suppl. 2), p.S49

2020

Volltextzugriff (PDF)

Immune function and response to neoadjuvant chemotherapy in hormone receptor positive, HER2-negative breast cancer

ANNALS OF ONCOLOGY, 2017, Vol.28 (Suppl. 5), p.v68-v68

2017

Volltextzugriff (PDF)

Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial

Breast cancer research and treatment, 2013-06, Vol.139 (3), p.751-758

2013

Volltextzugriff (PDF)

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Cell, 2018-05, Vol.173 (4), p.879-893.e13

2018

Volltextzugriff (PDF)

Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer

ESMO open, 2021-04, Vol.6 (2), p.100076, Article 100076

2021

Volltextzugriff (PDF)

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

Breast cancer research and treatment, 2012-02, Vol.131 (3), p.939-947

2012

Volltextzugriff (PDF)

Coronary Heart Disease Mortality After 5 Years of Adjuvant Tamoxifen Therapy: Results from a Randomized Trial

JNCI : Journal of the National Cancer Institute, 2005-11, Vol.97 (21), p.1609-1610

2005

Volltextzugriff (PDF)

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

Cancer cell, 2017-11, Vol.32 (5), p.669-683.e5

2017

Volltextzugriff (PDF)

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Journal of clinical oncology, 2012-07, Vol.30 (21), p.2601-2608

2012

Volltextzugriff (PDF)

Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel

Breast (Edinburgh), 2013-12, Vol.22 (6), p.1142-1147

2013

Volltextzugriff (PDF)

398 INVITED Should a Biopsy Be Done in Each Patient With a Suspicion of Metastatic Relapse?

European journal of cancer (1990), 2011, Vol.47, p.S87-S87

2011

Volltextzugriff (PDF)

Individuals With an Increased Risk of Colorectal Cancer: Perceived Benefits and Psychological Aspects of Surveillance by Means of Regular Colonoscopies

Journal of clinical oncology, 2004-05, Vol.22 (9), p.1736-1742

2004

Volltextzugriff (PDF)

A randomized study of individually tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy (FEC) for early breast cancer

JOURNAL OF CLINICAL ONCOLOGY, 2011, Vol.29 (15_suppl), p.1017-1017

2011

Volltextzugriff (PDF)

Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma

The Lancet (British edition), 1992-12, Vol.340 (8832), p.1369-1373

1992

Volltextzugriff (PDF)

4P Longitudinal proteogenomic profiling reveals therapeutic vulnerabilities of immunometabolism in breast cancer

Annals of oncology, 2022-05, Vol.33, p.S125-S125

2022

Volltextzugriff (PDF)

217P Heterogeneity of PD-L1 expression at the protein and mRNA levels in early breast cancer

Annals of oncology, 2020-09, Vol.31, p.S328-S328

2020

Volltextzugriff (PDF)

Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial

Clinical cancer research, 2023-02, Vol.29 (3), p.532-540

2023

Volltextzugriff (PDF)

Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer

Nature communications, 2024-05, Vol.15 (1), p.3837-3837, Article 3837

2024

Volltextzugriff (PDF)

Multiomic profiling reveals predictive molecular characteristics of response to neoadjuvant antibody-drug conjugate versus chemotherapy and dual HER2 blockade in HER2 positive breast cancer

European journal of cancer (1990), 2024-03, Vol.200, p.113830, Article 113830

2024

Volltextzugriff (PDF)

Separation of breast cancer and organ microenvironment transcriptomes in metastases

Breast cancer research : BCR, 2019-03, Vol.21 (1), p.36-36, Article 36

2019

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(306)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(319)
Japanisch
(13)
Deutsch
(12)
Schwedisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of The Society Of Chemical Industry
(33)
Transactions Of The Faraday Society
(30)
Acta Oncologica
(17)
Annals Of Oncology
(16)
Cancer Research
(14)
Breast Cancer Research And Treatment
(13)
Meiea
(12)
Nature
(10)
Journal Of Clinical Oncology
(8)
Breast
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial

Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

When to order a biopsy to characterise a metastatic relapse in breast cancer

Quantitation of cell loss in breast cancer during neoadjuvant treatment (NACT) assessed by serum thymidine kinase protein concentration (sTK1)

PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels

Immune function and response to neoadjuvant chemotherapy in hormone receptor positive, HER2-negative breast cancer

Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

Coronary Heart Disease Mortality After 5 Years of Adjuvant Tamoxifen Therapy: Results from a Randomized Trial

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel

398 INVITED Should a Biopsy Be Done in Each Patient With a Suspicion of Metastatic Relapse?

Individuals With an Increased Risk of Colorectal Cancer: Perceived Benefits and Psychological Aspects of Surveillance by Means of Regular Colonoscopies

A randomized study of individually tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy (FEC) for early breast cancer

Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma

4P Longitudinal proteogenomic profiling reveals therapeutic vulnerabilities of immunometabolism in breast cancer

217P Heterogeneity of PD-L1 expression at the protein and mRNA levels in early breast cancer

Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial

Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer

Multiomic profiling reveals predictive molecular characteristics of response to neoadjuvant antibody-drug conjugate versus chemotherapy and dual HER2 blockade in HER2 positive breast cancer

Separation of breast cancer and organ microenvironment transcriptomes in metastases

Suchergebnisse filtern